Immuron Limited (IMRN)
$1.04+0.00%Close
SELLCRISIS · day 13
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $7M
- Beta
- 0.51
- P/E (TTM)
- -3.33
- Short % float
- 0.91%
- Days to cover
- 1.0
- SI change
- -46.6%
- 1W
- -3.70%
- 1M
- -25.71%
- vs SPY 1W
- -3.57%
- vs SPY 1M
- -28.22%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on IMRN?
- LOPJLB’s latest quantitative signal on Immuron Limited (IMRN) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is IMRN in?
- Immuron Limited (IMRN) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Immuron Limited (IMRN) do?
- Immuron Limited is a biopharmaceutical company focused on the discovery, development, and global commercialization of polyclonal antibodies, with operations spanning Australia, the United States, and other international markets. The company's activities are structured into two key segments: Research and Development, and Hyperimmune Products. Currently, Immuron markets two key products. Travelan…